Full text
PDFPage 1215

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barth J. H., Cherry C. A., Wojnarowska F., Dawber R. P. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women. J Clin Endocrinol Metab. 1989 May;68(5):966–970. doi: 10.1210/jcem-68-5-966. [DOI] [PubMed] [Google Scholar]
- Boisselle A., Tremblay R. R. New therapeutic approach to the hirsute patient. Fertil Steril. 1979 Sep;32(3):276–279. doi: 10.1016/s0015-0282(16)44232-9. [DOI] [PubMed] [Google Scholar]
- Conway G. S., Jacobs H. S. Hirsutism. BMJ. 1990 Sep 29;301(6753):619–620. doi: 10.1136/bmj.301.6753.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hague W. M., Munro D. S., Sawers R. S., Duncan S. L., Honour J. W. Long-term effects of cyproterone acetate on the pituitary adrenal axis in adult women. Br J Obstet Gynaecol. 1982 Dec;89(12):981–984. doi: 10.1111/j.1471-0528.1982.tb04650.x. [DOI] [PubMed] [Google Scholar]
- Hammerstein J., Meckies J., Leo-Rossberg I., Moltz L., Zielske F. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem. 1975 Jun;6(6):827–836. doi: 10.1016/0022-4731(75)90311-8. [DOI] [PubMed] [Google Scholar]
